Mark E. Erwin

Continental Airlines, Inc. is an air carrier engaged in the business of transporting passengers, cargo and mail. The company operates in two business segments: mainline and regional. Continental Airlines was founded on July 15, 1934 and is headquartered in Houston, TX.

Cia Panameña de Aviación SA provides airline services. It operates daily scheduled flights to 30 destinations in 20 countries in North, Central, and South America, as well as in the Caribbean. The company also provides passengers with access to flights to more than 120 international destinations through code share agreements with Continental Airlines and other airlines. It was founded on August 15, 1947 and is headquartered in Panama City, Panama.

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Continental Micronesia, Inc. provides air transportation services. It also provides transporting passengers, cargo and mail in the Western Pacific. The company serves more than 23 cities in Pacific Rim, Micronesian Islands, and Hawaii. Continental Micronesia was founded in 1968 and is headquartered in Tamuning, Guam.

Centric Health Finance LLC provides outsourcing services in the fields of healthcare, pharmaceuticals, and medical devices under the VirtualPayor trade name. The company was founded on May 30, 2006 and is headquartered in Indianapolis, IN.

IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.